Posted by Michael Wonder on 26 Jul 2024
Tonix Pharmaceuticals granted fast track designation by FDA for Tonmya for fibromyalgia
25 July 2024 - NDA submission on track for second half 2024.
Tonix Pharmaceuticals today announced that the US FDA has granted fast track designation to Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the management of fibromyalgia.
